Cholesterol sets off chaotic blood vessel growth

May 29, 2013
Cholesterol sets off chaotic blood vessel growth
This shows disorganized blood vessels shown in AIBP knockdown zebrafish: Green, endothelial cells; red, fluorescent dextran injected to visualize the blood vessel lumen. Credit: UC San Diego School of Medicine

A study at the University of California, San Diego School of Medicine identified a protein that is responsible for regulating blood vessel growth by mediating the efficient removal of cholesterol from the cells. Unregulated development of blood vessels can feed the growth of tumors.

The work, led by Yury Miller, MD, PhD, associate professor of medicine at UC San Diego, will be published in the advance online edition of the journal Nature on May 29.

Cholesterol is a structural component of the cell and is indispensable for normal cellular function, although its excess often leads to abnormal proliferation, migration, inflammatory responses or cell death. The researchers studied how the removal of cholesterol from endothelial cells (cells that line the blood vessels) impacts the development of new blood vessels, the process called angiogenesis.

According to Miller, removal of excess cholesterol from endothelial cells is essential for restraining excessive growth of blood vessels.

"Too much cholesterol increases the abundance of , areas in the where initiate signaling events leading to angiogenesis," Miller said. VEGFR2 is such a receptor, playing a central role in the development of blood vessels. Research into the process of angiogenesis suggests that VEGF-induced signaling within endothelial cells is important to tumor growth.

In this study, the scientists show that apoA-I (AIBP) is secreted by surrounding tissues and facilitates cholesterol removal from . This process interferes with the VEGFR2 receptor function, in turn inhibiting angiogenesis.

"Studying the process in zebrafish, we found that the timing and the pattern of AIBP expression is such that it helps guide segmental arteries to grow strictly in the dorsal direction, instead of an aberrant sideways direction," said first author Longhou Fang, who added that future studies will explore if AIBP or its derivatives can be used to inhibit pathologic angiogenesis in tumors. Alternatively, blocking AIBP activity in the heart may, in principle, stimulate re-growth of blood vessels after a heart attack.

Explore further: Double drug combo could shut down abnormal blood vessel growth that feeds disease

More information: Control of angiogenesis by AIBP-mediated cholesterol efflux, DOI: 10.1038/nature12166

Related Stories

Double drug combo could shut down abnormal blood vessel growth that feeds disease

September 10, 2012
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal—such as cancer, diabetic ...

Study finds an on-off switch for angiogenesis

April 27, 2012
Scientists from the MIRA and MESA+ research institutes at the University of Twente (The Netherlands) have discovered an ‘on/off switch’ for angiogenesis in human tissue. Their research has shown that the growth ...

Lymphatic vasculature: A cholesterol removal system

March 25, 2013
Reverse cholesterol transport is a process in which accumulated cholesterol is removed from tissues, including the artery wall, and transported back to the liver for excretion. Little is known about how cholesterol is removed ...

XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants

April 8, 2013
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. ...

Dual effect on tumor blood vessels

May 31, 2012
Angiogenesis is considered to be a major target of new cancer treatments. Angiopoietin-2 (Ang-2) is one of the key regulators of angiogenesis. Scientists of the German Cancer Research Center and Medical Faculty Mannheim, ...

Recommended for you

Brain cells found to control aging

July 26, 2017
Scientists at Albert Einstein College of Medicine have found that stem cells in the brain's hypothalamus govern how fast aging occurs in the body. The finding, made in mice, could lead to new strategies for warding off age-related ...

Post-stroke patients reach terra firma with new exosuit technology

July 26, 2017
Upright walking on two legs is a defining trait in humans, enabling them to move very efficiently throughout their environment. This can all change in the blink of an eye when a stroke occurs. In about 80% of patients post-stroke, ...

Molecular hitchhiker on human protein signals tumors to self-destruct

July 24, 2017
Powerful molecules can hitch rides on a plentiful human protein and signal tumors to self-destruct, a team of Vanderbilt University engineers found.

Researchers develop new method to generate human antibodies

July 24, 2017
An international team of scientists has developed a method to rapidly produce specific human antibodies in the laboratory. The technique, which will be described in a paper to be published July 24 in The Journal of Experimental ...

New vaccine production could improve flu shot accuracy

July 24, 2017
A new way of producing the seasonal flu vaccine could speed up the process and provide better protection against infection.

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.